(2S)-1-(5-bromothiophen-2-yl)sulfonyl-N-(6-methyl-1,3-benzothiazol-2-yl)pyrrolidine-2-carboxamide
C17H16BrN3O3S3 — CID 25493284
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S)-1-(5-bromothiophen-2-yl)sulfonyl-N-(6-methyl-1,3-benzothiazol-2-yl)pyrrolidine-2-carboxamide
(2S)-1-(5-bromothiophen-2-yl)sulfonyl-N-(6-methyl-1,3-benzothiazol-2-yl)pyrrolidine-2-carboxamide (PubChem CID 25493284) has the molecular formula C17H16BrN3O3S3 and a molecular weight of 486.44 g/mol. Its IUPAC name is (2S)-1-(5-bromothiophen-2-yl)sulfonyl-N-(6-methyl-1,3-benzothiazol-2-yl)pyrrolidine-2-carboxamide.
Molecular Properties
| Compound Name | (2S)-1-(5-bromothiophen-2-yl)sulfonyl-N-(6-methyl-1,3-benzothiazol-2-yl)pyrrolidine-2-carboxamide |
|---|---|
| PubChem CID | 25493284 |
| Molecular Formula | C17H16BrN3O3S3 |
| Molecular Weight | 486.44 g/mol |
| Exact Mass | 484.95 |
| IUPAC Name | (2S)-1-(5-bromothiophen-2-yl)sulfonyl-N-(6-methyl-1,3-benzothiazol-2-yl)pyrrolidine-2-carboxamide |
| SMILES | Cc1ccc2nc(NC(=O)[C@@H]3CCCN3S(=O)(=O)c3ccc(Br)s3)sc2c1 |
| InChI | InChI=1S/C17H16BrN3O3S3/c1-10-4-5-11-13(9-10)25-17(19-11)20-16(22)12-3-2-8-21(12)27(23,24)15-7-6-14(18)26-15/h4-7,9,12H,2-3,8H2,1H3,(H,19,20,22)/t12-/m0/s1 |
| InChIKey | ICZKVNFOCJFEQU-LBPRGKRZSA-N |
| XLogP | 4.22 |
| TPSA | 79.37 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 486.44 |
| LogP ≤ 5 | 4.22 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 25493284 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.